QIIK:QSEQatar International Islamic Bank Analysis
Data as of 2026-03-14 - not real-time
QAR 11.26
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
QIIK trades at a trailing PE of 13.73, notably below the industry average of 16.35, suggesting a valuation edge. Operating margins remain robust at 38.8% and profit margin at 40.7%, yet revenue has slipped 22% year‑over‑year, raising questions on top‑line momentum. The stock sits comfortably above its technical support of QAR 10.44 and below resistance at QAR 11.75, with the 20‑day SMA (11.32) marginally under the 50‑day SMA (11.45) and a bullish MACD signal, indicating a neutral‑to‑slightly‑positive short‑term bias. Volatility is moderate at 21.5% over 30 days, while beta is very low (0.13), reflecting limited market‑wide price swings. Dividend yield stands out at 4.71% with a payout ratio of 62%, but operating cash flow is negative, casting doubt on long‑term sustainability. Overall, the combination of undervalued multiples, solid profitability, and a high yield makes the stock attractive, though earnings growth and cash generation remain key concerns.
Investors should weigh the upside potential of roughly 4% against the backdrop of declining revenues and cash flow weakness. The low beta and increasing volume suggest decent liquidity, but regulatory and sector‑specific risks inherent to regional banking warrant a cautious stance, especially for longer horizons.
Investors should weigh the upside potential of roughly 4% against the backdrop of declining revenues and cash flow weakness. The low beta and increasing volume suggest decent liquidity, but regulatory and sector‑specific risks inherent to regional banking warrant a cautious stance, especially for longer horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD signal with a small positive histogram
- Price above support at QAR 10.44 offering ~4% upside
- High dividend yield of 4.71% enhancing total return
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue contraction of 22% challenges earnings sustainability
- Strong operating margin (38.8%) supports profitability
- Valuation remains below industry PE average, limiting downside risk
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Undervalued relative to peers on PE and PB metrics
- Dividend payout ratio at 62% may strain cash flow over time
- Stable regulatory environment but sector exposure to regional banking risks
Key Metrics & Analysis
Financial Health
Revenue Growth-22.20%
Profit Margin40.69%
P/E Ratio13.7
ROE13.75%
ROA2.20%
P/B Ratio2.1
Op. Cash FlowQAR-1466403968
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI48.4
SupportQAR 10.44
ResistanceQAR 11.75
MA 20QAR 11.32
MA 50QAR 11.45
MA 200QAR 11.19
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target PriceQAR 11.73
Upside/Downside4.17%
GradeUndervalued
TypeValue
Dividend Yield4.71%
Risk Assessment
Beta0.17
Volatility21.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.